文献速递功能神经外科

单侧苍白丘脑束切断术治疗僵直迟缓型帕金森病的前瞻性开放标签研究

Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study.
PubMed 文献 · J Neurosurg · 2021-01-15

这项前瞻性开放标签研究纳入14例僵直迟缓型帕金森病患者,行单侧苍白丘脑束切断术,最终10例完成12个月随访。术后12个月MDS-UPDRS Part III总分、对侧僵直和运动迟缓显著改善,异动症和肌张力障碍评分大幅下降,左旋多巴等效日剂量无显著变化,未观察到严重永久性神经功能缺损。

要点

  • 单侧苍白丘脑束切断术可显著改善僵直迟缓型帕金森病对侧僵直和运动迟缓。
  • 术后异动症和肌张力障碍评分分别下降79.2%和91.7%,左旋多巴等效日剂量无显著变化。
  • 部分患者出现发音过弱、眼睑失用或左旋多巴反应下降,但无严重永久性神经功能缺损。

核心结论

  • 单侧苍白丘脑束切断术可改善僵直迟缓型帕金森病患者对侧僵直、运动迟缓、异动症和肌张力障碍。

研究设计与样本

  • 前瞻性开放标签研究,纳入14例僵直迟缓型帕金森病患者行单侧苍白丘脑束切断术,4例失访,最终分析10例。

主要发现

  • MDS-UPDRS Part III总分从基线45±4.6改善至术后12个月32.9±4.8(p=0.005)。
  • 对侧僵直从基线4.4±0.5改善至术后12个月1.7±0.4(p=0.005),对侧运动迟缓从10.4±1.5改善至5.2±1.4(p=0.011)。
  • 姿势评分降低20%(p=0.038),步态无显著改善(p=0.066)。
  • 异动症评分降低79.2%(p=0.0012),肌张力障碍评分降低91.7%(p=0.041),左旋多巴等效日剂量无显著变化。
  • 2例出现发音过弱,1例出现眼睑失用,3例因左旋多巴反应下降而增加每日剂量,未观察到严重永久性神经功能缺损。

临床怎么用

  • 对于药物难治性僵直迟缓型帕金森病患者,单侧苍白丘脑束切断术可作为改善对侧僵直、运动迟缓及异动症、肌张力障碍的备选干预方式。

局限性

  • 研究为开放标签设计,样本量小且存在失访(14例中4例失访),随访至术后12个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Neurosurgical ablation is an effective treatment for medically refractory motor symptoms of Parkinson's disease (PD). A limited number of studies have reported the effect of ablation of the pallidothalamic tract for PD. In this study, the authors evaluated the safety and efficacy of unilateral pallidothalamic tractotomy for akinetic-rigid (AR)-PD. METHODS: Fourteen AR-PD patients, who were enrolled in this prospective open-label study, underwent unilateral pallidothalamic tractotomy. The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III and Part IV (dyskinesia and dystonia) scores and levodopa equivalent daily dose (LEDD) were evaluated at baseline and at 3 and 12 months postoperatively. RESULTS: Of the 14 patients enrolled in the study, 4 were lost to follow-up and 10 were analyzed. The total MDS-UPDRS Part III score significantly improved from 45 ± 4.6 at baseline to 32.9 ± 4.8 at 12 months postoperatively (p = 0.005). Contralateral side rigidity and bradykinesia significantly improved from 4.4 ± 0.5 and 10.4 ± 1.5 at baseline to 1.7 ± 0.4 (p = 0.005) and 5.2 ± 1.4 (p = 0.011) at 12 months, respectively. While posture significantly improved with a 20% reduction in scores (p = 0.038), no significant improvement was found in gait (p = 0.066). Dyskinesia and dystonia were improved with a 79.2% (p = 0.0012) and 91.7% (p = 0.041) reduction in scores, respectively. No significant change was found in the LEDD. Hypophonia was noted in 2 patients, eyelid apraxia was noted in 1 patient, and a reduced response to levodopa, which resulted in an increase in the daily dose of levodopa, was noted in 3 patients. No serious permanent neurological deficits were observed. CONCLUSIONS: Unilateral pallidothalamic tractotomy improved contralateral side rigidity and bradykinesia, dyskinesia, and dystonia in patients with AR-PD. Clinical trial registration no.: UMIN000031138 (umin.ac.jp).

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Horisawa S, Fukui A, Yamahata H, et al. Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study. J Neurosurg. 2021. PMID: 33450738. doi:10.3171/2020.7.JNS201547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。